Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Rheumatoid Arthritis

  Free Subscription

Articles published in Scand J Rheumatol

Retrieve available abstracts of 87 articles:
HTML format

Single Articles

    July 2024
  1. SOUSSI BG, Cordtz RL, Duch K, Kristensen S, et al
    Incidence of seropositive and seronegative rheumatoid arthritis in Denmark: a nationwide population-based study.
    Scand J Rheumatol. 2024 Jul 8:1-9. doi: 10.1080/03009742.2024.2365540.
    PubMed     Abstract available

  2. TESTA D, Bilia S, Tavoni AG, Migliorini P, et al
    Adult-onset Still's disease: analysis of a monocentric cohort of patients.
    Scand J Rheumatol. 2024;53:263-268.
    PubMed     Abstract available

  3. AYANO M, Tsubouchi K, Suzuki K, Kimoto Y, et al
    Comparing the safety and efficacy of nintedanib starting dose in patients with connective tissue disease-associated interstitial lung diseases.
    Scand J Rheumatol. 2024;53:255-262.
    PubMed     Abstract available

  4. YOSHIHARA R, Tsuchiya H, Shoda H, Fujio K, et al
    Relationship between earlier introduction of tocilizumab and glucocorticoid-sparing effects on the acute phase of adult-onset Still's disease.
    Scand J Rheumatol. 2024;53:284-287.

    June 2024
  5. FARINA N, Tomelleri A, Boffini N, Cariddi A, et al
    Retention rates of different Janus kinase inhibitors in rheumatoid arthritis: experience from a large monocentric cohort.
    Scand J Rheumatol. 2024 Jun 4:1-5. doi: 10.1080/03009742.2024.2353433.
    PubMed     Abstract available

    May 2024
  6. PROVAN SA, Ahlfors F, Bakland G, Hu Y, et al
    A validation of register-derived diagnoses of interstitial lung disease in patients with inflammatory arthritis: data from the NOR-DMARD study.
    Scand J Rheumatol. 2024;53:173-179.
    PubMed     Abstract available

  7. GERTEL S, Rokach M, Polachek A, Litinsky I, et al
    Anti-inflammatory effects of infliximab and methotrexate on peripheral blood and synovial fluid mononuclear cells: ex vivo study.
    Scand J Rheumatol. 2024;53:188-198.
    PubMed     Abstract available

    April 2024
  8. LI Z, Lei S, Zhou S, Zhang Z, et al
    Rheumatoid arthritis with chylothorax: a case report.
    Scand J Rheumatol. 2024 Apr 30:1-2. doi: 10.1080/03009742.2024.2342053.

    March 2024
  9. AHAMMAR S, Martinsson K, Ziegelasch M, Kastbom A, et al
    Prognostic value of serum protein electrophoresis constituents for arthritis development in anti-citrullinated protein antibody-positive patients with musculoskeletal pain.
    Scand J Rheumatol. 2024;53:118-122.
    PubMed     Abstract available

    February 2024
  10. WANG J, Vordenbaumen S, Schneider M, Brinks R, et al
    Population-based epidemiological projections of rheumatoid arthritis in Germany until 2040.
    Scand J Rheumatol. 2024 Feb 15:1-12. doi: 10.1080/03009742.2024.2312693.
    PubMed     Abstract available

    January 2024
  11. HOUGE IS, Hoff M, Videm V
    Self-determined motivation and physical activity in patients with rheumatoid arthritis: a cross-sectional study.
    Scand J Rheumatol. 2024 Jan 26:1-9. doi: 10.1080/03009742.2023.2300576.
    PubMed     Abstract available

  12. YOO WH, Ha GW, Kim KM, Choi Y, et al
    When treatment takes a turn: tocilizumab-induced bowel perforation in a patient with COVID-19-afflicted rheumatoid arthritis.
    Scand J Rheumatol. 2024 Jan 10:1-3. doi: 10.1080/03009742.2023.2294580.

  13. ROGIND SS, Hetland ML
    Delayed identification of disseminated infection in a patient with rheumatoid arthritis and septic arthritis: a case report.
    Scand J Rheumatol. 2024;53:72-73.

    December 2023
  14. MICHITSUJI T, Fukui S, Morimoto S, Endo Y, et al
    Clinical and ultrasound features of difficult-to-treat rheumatoid arthritis: A multicenter RA ultrasound cohort study.
    Scand J Rheumatol. 2023 Dec 12:1-7. doi: 10.1080/03009742.2023.2277542.
    PubMed     Abstract available

    November 2023
  15. KOMAI T, Sawada T, Tsuchiya H, Harada H, et al
    Resolution of exacerbated rheumatoid arthritis-associated interstitial lung disease under baricitinib treatment.
    Scand J Rheumatol. 2023 Nov 30:1-3. doi: 10.1080/03009742.2023.2274707.

  16. VAN WISSEN M, Straathof B, Vliet Vlieland T, van den Ende C, et al
    Construct validity of the PROMIS PF-10 in patients with inflammatory rheumatic diseases and severe limitations in physical functioning.
    Scand J Rheumatol. 2023;52:645-653.
    PubMed     Abstract available

  17. ZENG M, Issotina Zibrila A, Li X, Liu X, et al
    Pyridostigmine ameliorates pristane-induced arthritis symptoms in Dark Agouti rats.
    Scand J Rheumatol. 2023;52:627-636.
    PubMed     Abstract available

    October 2023
  18. BELAU MH, Flasskamp F, Becher H, Hajek A, et al
    Physical activity in adults with and without rheumatoid arthritis: cross-sectional results from the Survey of Health, Ageing and Retirement in Europe (SHARE).
    Scand J Rheumatol. 2023 Oct 31:1-6. doi: 10.1080/03009742.2023.2269672.
    PubMed     Abstract available

    September 2023
  19. ZHANG Y, Zhu F, Liu C, Wang M, et al
    A case report of Sjogren's syndrome complicated with immune-mediated necrotizing myopathy.
    Scand J Rheumatol. 2023;52:580-583.

  20. UHRENHOLT L, Christensen R, Dreyer L, Hauge EM, et al
    Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trial.
    Scand J Rheumatol. 2023;52:481-492.
    PubMed     Abstract available

  21. PFEIFFER-JENSEN M, Liao D, Tarp U, Deleuran B, et al
    Reduced prescription of TNF-inhibitors in chronic arthritis based on therapeutic drug monitoring: A randomized controlled trial.
    Scand J Rheumatol. 2023;52:468-480.
    PubMed     Abstract available

    July 2023
  22. MCKEIGUE PM, Porter D, Hollick RJ, Ralston SH, et al
    Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland.
    Scand J Rheumatol. 2023;52:412-417.
    PubMed     Abstract available

    June 2023
  23. SAHIN EROGLU D, Dalva K, Azap A, Kutlay NY, et al
    Two birds with one stone: a Bruton's tyrosine kinase inhibitor in a patient with rheumatoid arthritis and 17p + chronic lymphocytic leukaemia.
    Scand J Rheumatol. 2023 Jun 28:1-2. doi: 10.1080/03009742.2023.2218206.

    May 2023
  24. DE STEFANO L, Guerini M, Pelizza J, Ferracane G, et al
    A case of a rheumatoid nodule on the aortic valve in a patient with rheumatoid arthritis in sustained remission with anti-TNFalpha.
    Scand J Rheumatol. 2023 May 4:1-3. doi: 10.1080/03009742.2023.2201065.

  25. VAN WISSEN M, Gademan M, Vliet Vlieland T, Straathof B, et al
    Physical therapy in patients with rheumatoid arthritis and axial spondyloarthritis: the patients' perspective.
    Scand J Rheumatol. 2023 May 4:1-10. doi: 10.1080/03009742.2023.2195726.
    PubMed     Abstract available

    April 2023
  26. FERREIRA MB, Kobayashi M, Costa RQ, Fonseca T, et al
    Unsupervised clustering to differentiate rheumatoid arthritis patients based on proteomic signatures.
    Scand J Rheumatol. 2023 Apr 21:1-8. doi: 10.1080/03009742.2023.2196781.
    PubMed     Abstract available

  27. HYLDGAARD C, Harders S, Blegvad J, Herly M, et al
    Clinical and preclinical pulmonary disease in newly diagnosed rheumatoid arthritis: a two-year follow-up study.
    Scand J Rheumatol. 2023 Apr 17:1-8. doi: 10.1080/03009742.2023.2194105.
    PubMed     Abstract available

    March 2023
  28. BLANKEN AB, Korteweg M, van Boheemen L, van Vollenhoven RF, et al
    Clinical evaluation of optical spectral transmission imaging for detection of disease activity in rheumatoid arthritis.
    Scand J Rheumatol. 2023 Mar 28:1-9. doi: 10.1080/03009742.2023.2177382.
    PubMed     Abstract available

  29. RASMUSSEN SL, Strandbygaard LL, Fuursted K, Kragholm KH, et al
    Antibody response in patients with autoimmune inflammatory rheumatic disease after pneumococcal polysaccharide prime vaccination or revaccination.
    Scand J Rheumatol. 2023;52:174-180.
    PubMed     Abstract available

  30. OLSSON P, Ekblad F, Hassler A, Bengtsson M, et al
    Complications after minor salivary gland biopsy: a retrospective study of 630 patients from two Swedish centres.
    Scand J Rheumatol. 2023;52:208-216.
    PubMed     Abstract available

  31. YU X, Zhu F, Yu X, Wang J, et al
    Serum CCL28 as a biomarker for diagnosis and evaluation of Sjogren's syndrome.
    Scand J Rheumatol. 2023;52:200-207.
    PubMed     Abstract available

    February 2023
  32. KARLSSON ML, Hertzberg-Nyquist K, Saevarsdottir S, Lundberg IE, et al
    Evaluation of an individually tailored smoking-cessation intervention for patients with rheumatoid arthritis in an outpatient clinic.
    Scand J Rheumatol. 2023 Feb 23:1-11. doi: 10.1080/03009742.2023.2172903.
    PubMed     Abstract available

  33. LANDGREN AJ, Klingberg E, Jacobsson L, Bergsten U, et al
    Health-related quality of life in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis, results from a cross-sectional survey in Western Sweden.
    Scand J Rheumatol. 2023 Feb 6:1-13. doi: 10.1080/03009742.2022.2157962.
    PubMed     Abstract available

    January 2023
  34. KOERS J, Derksen N, Falkenburg W, Ooijevaar-de Heer P, et al
    Elevated Fab glycosylation of anti-hinge antibodies.
    Scand J Rheumatol. 2023;52:25-32.
    PubMed     Abstract available

    November 2022
  35. LIAO HT, Tung HY, Chou CT, Tsai HC, et al
    Immunogenicity of the mRNA-1273 and ChAdOx1 nCoV-19 vaccines in Asian patients with autoimmune rheumatic diseases under biologic and/or conventional immunosuppressant treatments.
    Scand J Rheumatol. 2022;51:500-505.
    PubMed     Abstract available

    October 2022
  36. RASMUSSEN EB, Thiele LS, Stengaard-Pedersen K, Hetland ML, et al
    Baseline serum levels of IgA anti-cyclic citrullinated protein antibodies in early rheumatoid arthritis predict radiographic progression after 11 years of treatment: a secondary analysis of the CIMESTRA study.
    Scand J Rheumatol. 2022 Oct 18:1-5. doi: 10.1080/03009742.2022.2127245.
    PubMed     Abstract available

    September 2022
  37. SIMONS G, Scholin Bywall K, Englbrecht M, Johansson EC, et al
    Exploring preferences of at-risk individuals for preventive treatments for rheumatoid arthritis.
    Scand J Rheumatol. 2022 Sep 30:1-11. doi: 10.1080/03009742.2022.2116805.
    PubMed     Abstract available

  38. VAN BOHEEMEN L, Ter Wee MM, Falahee M, Filer A, et al
    The Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: predicting clinical arthritis development.
    Scand J Rheumatol. 2022 Sep 29:1-8. doi: 10.1080/03009742.2022.2116806.
    PubMed     Abstract available

    July 2022
  39. HU H, Wang S
    Rheumatoid arthritis with coral reef aorta: a case report.
    Scand J Rheumatol. 2022 Jul 14:1-2. doi: 10.1080/03009742.2022.2082150.

  40. RAFT MB, Hetland ML, Brahe CH, Horslev-Petersen K, et al
    Serum 14-3-3eta as predictor of clinical remission and progression of structural damage in early rheumatoid arthritis following a treat-to-target strategy in a randomized controlled trial.
    Scand J Rheumatol. 2022 Jul 14:1-11. doi: 10.1080/03009742.2022.2087900.
    PubMed     Abstract available

  41. CHEN D, Yin H, Tang G, Lu L, et al
    Efficacy of low-dose of baricitinib in the treatment of patchy alopecia and sicca syndrome in an SLE patient.
    Scand J Rheumatol. 2022 Jul 14:1-3. doi: 10.1080/03009742.2022.2087901.

  42. KRIJBOLDER DI, Verstappen M, Wouters F, Lard LR, et al
    Comparison between 1.5T and 3.0T MRI: both field strengths sensitively detect subclinical inflammation of hand and forefoot in patients with arthralgia.
    Scand J Rheumatol. 2022;51:284-290.
    PubMed     Abstract available

    June 2022
  43. ZHANG K, Jia Y, Wang R, Guo D, et al
    Rheumatoid arthritis and the risk of major cardiometabolic diseases: a Mendelian randomization study.
    Scand J Rheumatol. 2022 Jun 6:1-7. doi: 10.1080/03009742.2022.2070988.
    PubMed     Abstract available

    May 2022
  44. VENETSANOPOULOU AI, Alamanos Y, Skalkou A, Voulgari PV, et al
    The changing incidence of rheumatoid arthritis over time in north-west Greece: data from a referral centre.
    Scand J Rheumatol. 2022 May 12:1-8. doi: 10.1080/03009742.2022.2058178.
    PubMed     Abstract available

  45. LEE NY, Kim NR, Kang JW, Kim G, et al
    Increased salivary syndecan-1 level is associated with salivary gland function and inflammation in patients with Sjogren's syndrome.
    Scand J Rheumatol. 2022;51:220-229.
    PubMed     Abstract available

  46. FOHSE FK, Rollefstad S, Ikdahl E, Wibetoe G, et al
    Degree of arterial stiffness is comparable across inflammatory joint disease entities.
    Scand J Rheumatol. 2022;51:186-195.
    PubMed     Abstract available

    April 2022
  47. DIEPERINK SS, Glintborg B, Oestergaard LB, Norgaard M, et al
    Risk of Staphylococcus aureus bacteraemia in patients with rheumatoid arthritis and the effect of orthopaedic implants on the risk: a nationwide observational cohort study.
    Scand J Rheumatol. 2022 Apr 20:1-9. doi: 10.1080/03009742.2022.2049057.
    PubMed     Abstract available

    March 2022
  48. HESLINGA M, Teunissen C, Agca R, van der Woude D, et al
    NT-proBNP and sRAGE levels in early rheumatoid arthritis.
    Scand J Rheumatol. 2022 Mar 11:1-7. doi: 10.1080/03009742.2022.2042975.
    PubMed     Abstract available

  49. ALSING CL, Nystad TW, Igland J, Gjesdal CG, et al
    Trends in the occurrence of ischaemic heart disease over time in rheumatoid arthritis: 1821 patients from 1972 to 2017.
    Scand J Rheumatol. 2022 Mar 11:1-10. doi: 10.1080/03009742.2022.2040116.
    PubMed     Abstract available

  50. RUWAARD J, L' Ami MJ, Kneepkens EL, Krieckaert C, et al
    Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial.
    Scand J Rheumatol. 2022 Mar 2:1-8. doi: 10.1080/03009742.2022.2028364.
    PubMed     Abstract available

  51. LIU Y, Wang Z, Ren L, Zeng Q, et al
    Sonographic findings of immunoglobulin G4-related sialadenitis and differences from Sjogren's syndrome.
    Scand J Rheumatol. 2022;51:128-134.
    PubMed     Abstract available

    January 2022
  52. SKOVSGAARD CV, Kruse M, Hjollund N, Maribo T, et al
    Cost-effectiveness of a telehealth intervention in rheumatoid arthritis: economic evaluation of the Telehealth in RA (TeRA) randomized controlled trial.
    Scand J Rheumatol. 2022 Jan 20:1-11. doi: 10.1080/03009742.2021.2008604.
    PubMed     Abstract available

  53. NIELSEN MA, Koster D, Greisen S, Troldborg A, et al
    Increased synovial galectin-3 induce inflammatory fibroblast activation and osteoclastogenesis in patients with rheumatoid arthritis.
    Scand J Rheumatol. 2022 Jan 13:1-9. doi: 10.1080/03009742.2021.1992860.
    PubMed     Abstract available

  54. MOLANDER V, Bower H, Askling J
    Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis.
    Scand J Rheumatol. 2022 Jan 13:1-7. doi: 10.1080/03009742.2021.2001907.
    PubMed     Abstract available

  55. GLOYER L, Golumba-Nagy V, Meyer A, Yan S, et al
    Adenosine receptor A2a blockade by caffeine increases IFN-gamma production in Th1 cells from patients with rheumatoid arthritis.
    Scand J Rheumatol. 2022 Jan 13:1-5. doi: 10.1080/03009742.2021.1995956.
    PubMed     Abstract available

  56. CARRARA G, Argnani L, Zanetti A, Zabotti A, et al
    Persistence of bDMARD therapy in Rheumatoid Arthritis after first-line TNF-inhibitor failure: the RECORD study of the Italian Society for Rheumatology.
    Scand J Rheumatol. 2022 Jan 13:1-5. doi: 10.1080/03009742.2021.2003033.
    PubMed     Abstract available

  57. KEROLA AM, Rollefstad S, Kazemi A, Wibetoe G, et al
    Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents.
    Scand J Rheumatol. 2022 Jan 11:1-9. doi: 10.1080/03009742.2021.1997436.
    PubMed     Abstract available

  58. UHRENHOLT L, Christensen R, Dreyer L, Schlemmer A, et al
    Using a novel smartphone application for capturing of patient-reported outcome measures among patients with inflammatory arthritis:A randomized, crossover, agreement study.
    Scand J Rheumatol. 2022;51:25-33.
    PubMed     Abstract available

  59. OTTAVIANI S, Khaleche S, Borie R, Debray MP, et al
    Rheumatological evaluation of patients with interstitial lung disease.
    Scand J Rheumatol. 2022;51:34-41.
    PubMed     Abstract available

  60. KITADA T, Kadoba K, Watanabe R, Koyama T, et al
    Listeriosis presenting with fever, arthralgia, elevated liver enzymes, and hyperferritinaemia in pregnancy: a critical mimicker of adult-onset Still's disease.
    Scand J Rheumatol. 2022;51:78-80.

    December 2021
  61. SOUSSI BG, Cordtz RL, Kristensen S, Bork CS, et al
    Incidence and prevalence of rheumatoid arthritis in Denmark from 1998 to 2018: a nationwide register-based study.
    Scand J Rheumatol. 2021 Dec 16:1-9. doi: 10.1080/03009742.2021.1957557.
    PubMed     Abstract available

    November 2021
  62. THOMSEN T, Esbensen BA, Hetland ML, Aadahl M, et al
    Characteristics of participants and decliners from a randomized controlled trial on physical activity in patients with rheumatoid arthritis: a retrospective register-based cross-sectional study.
    Scand J Rheumatol. 2021 Nov 2:1-8. doi: 10.1080/03009742.2021.1975394.
    PubMed     Abstract available

  63. GEHIN JE, Warren DJ, Syversen SW, Lie E, et al
    Serum golimumab concentration and anti-drug antibodies are associated with treatment response and drug survival in patients with inflammatory joint diseases: data from the NOR-DMARD study.
    Scand J Rheumatol. 2021;50:445-454.
    PubMed     Abstract available

    October 2021
  64. PALTTA J, Heikkila HK, Pirila L, Eklund KK, et al
    The validity of rheumatoid arthritis diagnoses in Finnish biobanks.
    Scand J Rheumatol. 2021 Oct 13:1-9. doi: 10.1080/03009742.2021.1967047.
    PubMed     Abstract available

  65. ANGSTROM L, Hornberg K, Sundstrom B, Sodergren A, et al
    Rheumatoid cachexia in early rheumatoid arthritis: prevalence and associated variables.
    Scand J Rheumatol. 2021 Oct 13:1-7. doi: 10.1080/03009742.2021.1973678.
    PubMed     Abstract available

  66. AMRIS K, Bandak E, Kristensen LE, Waehrens EE, et al
    Agreement between self-reported and observed functioning in patients with rheumatoid arthritis, osteoarthritis, and fibromyalgia, and the influence of pain and fatigue: a cross-sectional study.
    Scand J Rheumatol. 2021 Oct 1:1-9. doi: 10.1080/03009742.2021.1952755.
    PubMed     Abstract available

    September 2021
  67. JENSEN R, Christensen AF, Hartlev LB, Thomsen JS, et al
    Calcified cartilage differs in patients with end-stage primary osteoarthritis and secondary osteoarthritis due to rheumatoid arthritis of the hip joint.
    Scand J Rheumatol. 2021 Sep 13:1-11. doi: 10.1080/03009742.2021.1952754.
    PubMed     Abstract available

  68. THOMAS PE, Aarestrup J, Jacobsen S, Jensen BW, et al
    Birthweight, body size, and growth during childhood and risks of rheumatoid arthritis: a large Danish cohort study.
    Scand J Rheumatol. 2021 Sep 13:1-9. doi: 10.1080/03009742.2021.1954772.
    PubMed     Abstract available

  69. BERTRAND D, Stouten V, De Cock D, Pazmino S, et al
    Tapering of Etanercept is feasible in patients with Rheumatoid Arthritis in sustained remission: a pragmatic randomized controlled trial.
    Scand J Rheumatol. 2021 Sep 13:1-11. doi: 10.1080/03009742.2021.1955467.
    PubMed     Abstract available

  70. MARS N, Kerola AM, Kauppi MJ, Pirinen M, et al
    Cluster analysis identifies unmet healthcare needs among patients with rheumatoid arthritis.
    Scand J Rheumatol. 2021 Sep 13:1-8. doi: 10.1080/03009742.2021.1944306.
    PubMed     Abstract available

  71. NAKAYAMA Y, Hashimoto M, Watanabe R, Murakami K, et al
    Favorable clinical response and drug retention of anti-IL-6 receptor inhibitor in rheumatoid arthritis with high CRP levels: the ANSWER cohort study.
    Scand J Rheumatol. 2021 Sep 13:1-10. doi: 10.1080/03009742.2021.1947005.
    PubMed     Abstract available

  72. MOLLER-BISGAARD S, Horslev-Petersen K, Ejbjerg B, Hetland ML, et al
    Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial.
    Scand J Rheumatol. 2021 Sep 2:1-11. doi: 10.1080/03009742.2021.1935312.
    PubMed     Abstract available

  73. ENDO Y, Kawashiri SY, Nishino A, Michitsuji T, et al
    Ultrasound efficacy of targeted-synthetic disease-modifying anti-rheumatic drug treatment in rheumatoid arthritis: a multicenter prospective cohort study in Japan.
    Scand J Rheumatol. 2021 Sep 2:1-9. doi: 10.1080/03009742.2021.1927389.
    PubMed     Abstract available

  74. ANDERSSON M, Svensson B, Bergman S
    Pain in rheumatoid arthritis: a seven-year follow-up study of pain distribution and factors associated with transition from and to chronic widespread pain.
    Scand J Rheumatol. 2021 Sep 1:1-10. doi: 10.1080/03009742.2021.1944304.
    PubMed     Abstract available

  75. CIAFFI J, Giuggioli D, Spinella A, Meliconi R, et al
    Resilience of systemic sclerosis patients following the first COVID-19 wave in Italy.
    Scand J Rheumatol. 2021;50:411-412.

    July 2021
  76. VUOLTEENAHO K, Tuure L, Nieminen R, Laasonen L, et al
    Pretreatment resistin levels are associated with erosive disease in early rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs and infliximab.
    Scand J Rheumatol. 2021 Jul 15:1-6. doi: 10.1080/03009742.2021.1929456.
    PubMed     Abstract available

  77. CAO C, Shao Q, Yang H
    Sjogren's syndrome concurrent with organizing pneumonia with secondary systemic capillary leak syndrome: a case report.
    Scand J Rheumatol. 2021;50:322-324.

    June 2021
  78. PEDERSEN JK, Andersen K, Svendsen AJ, Horslev-Petersen K, et al
    No difference in antidepressant prescription in rheumatoid arthritis and controls. Results from a population-based, matched inception cohort.
    Scand J Rheumatol. 2021 Jun 29:1-7. doi: 10.1080/03009742.2021.1923148.
    PubMed     Abstract available

  79. MCCOY SS, Greenlee RT, VanWormer JJ, Schletzbaum M, et al
    Smoking associated with reduced odds of Sjogren's syndrome among rheumatoid arthritis patients.
    Scand J Rheumatol. 2021 Jun 25:1-5. doi: 10.1080/03009742.2021.1925584.
    PubMed     Abstract available

  80. VERSTEEG GA, Steunebrink L, Vonkeman HE, Ten Klooster PM, et al
    Early radiological progression remains associated with long-term joint damage in real-world rheumatoid arthritis patients treated to the target of remission.
    Scand J Rheumatol. 2021 Jun 21:1-10. doi: 10.1080/03009742.2021.1917161.
    PubMed     Abstract available

  81. TAN YK, Teo P, Saffari SE, Xin X, et al
    A musculoskeletal ultrasound program as an intervention to improve disease modifying anti-rheumatic drugs adherence in rheumatoid arthritis: a randomized controlled trial.
    Scand J Rheumatol. 2021 Jun 10:1-9. doi: 10.1080/03009742.2021.1901416.
    PubMed     Abstract available

    May 2021
    Early description of polyarthritis possibly representing rheumatoid arthritis given by a patient, as recorded in a textbook on gout from 1788.
    Scand J Rheumatol. 2021 May 5:1-2. doi: 10.1080/03009742.2021.1894824.

  83. ELOFF E, Martinsson K, Ziegelasch M, Cedergren J, et al
    Autoantibodies are major predictors of arthritis development in patients with anti-citrullinated protein antibodies and musculoskeletal pain.
    Scand J Rheumatol. 2021;50:189-197.
    PubMed     Abstract available

    April 2021
  84. GAO J, Xin L, Guo Q, Xu K, et al
    Twenty-year changes in mortality rates and underlying causes of death in patients with rheumatoid arthritis-associated interstitial lung disease.
    Scand J Rheumatol. 2021 Apr 14:1-5. doi: 10.1080/03009742.2021.1882557.
    PubMed     Abstract available

    March 2021
  85. SHAO Q, Wang S, Jiang H, Liu L, et al
    Efficacy and safety of iguratimod on patients with primary Sjogren's syndrome: a randomized, placebo-controlled clinical trial.
    Scand J Rheumatol. 2021;50:143-152.
    PubMed     Abstract available

  86. KONONOFF A, Horkko S, Pussinen P, Kautiainen H, et al
    Antibodies to malondialdehyde-acetaldehyde modified low-density lipoprotein in patients with newly diagnosed inflammatory joint disease.
    Scand J Rheumatol. 2021;50:113-117.
    PubMed     Abstract available

  87. LAVERE P, Sonkar J, Du X, Qian YW, et al
    Macrophage activation syndrome complicating adult onset Still's disease: a case report.
    Scand J Rheumatol. 2021;50:161-162.

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.